Skip to main content

Identification of Immunoreactive LTB4 in the Yeast-inflamed Rat Paw

  • Chapter

Abstract

The yeast-inflamed rat paw model (1) has been used extensively to evaluate analgesic agents and a role for prostaglandins as mediators of hyperalgesia in this model is well accepted. In 1965 Winter and Flataker (2) showed that non-steroidal anti-inflammatory drugs inhibited the yeast-induced hyperalgesia without affecting oedema and later, Tyers and Haywood (3) proposed that prostaglandins, in particular PGE2, acted by sensitising primary afferent neurones to stimulation by other nociceptive agents. More recently, attention has focused on the possible role of lipoxygenase metabolites as mediators of hyperalgesia and oedema in this model. Rackham and Ford-Hutchinson (4) showed that LTB4 reversed the initial hypoalgesia and shortened the onset of hyperalgesia when injected concomitantly with yeast, in a similar manner to PGE1. However, rather than having a pro-inflammatory effect, LTB4 reduced the yeast-induced oedema. In similar experiments, line peptidyl leukotriene, LTD4, had no effect on yeast-induced hyperalgesia or oedema.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Randall, L.O. and Selitto, J.J. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111, 409–419.

    Google Scholar 

  2. Winter, C.A. and Flataker, L. (1965). Nociceptive thresholds as affected by parenteral administration of irritants and of various anti-nociceptive drugs. J. Pharmacol. Exp. Ther., 148, 373–379.

    Google Scholar 

  3. Tyers, M.B. and Haywood, H. (1979). Effects of prostaglandins on peripheral nociceptors in acute inflammation. In Prostaglandins and Inflammation (eds. K.D. Rainsford and A.W. Ford-Hutchinson) Birkhauser, Basel, pp. 65–78.

    Chapter  Google Scholar 

  4. Rackham, A. and Ford-Hutchinson, A.W. (1983). Inflammation and pain sensitivity: effects of leukotrienes D4, B4. and prostaglandin E1 in the rat paw. Prostaglandins, 25, 193–203.

    Article  Google Scholar 

  5. Forder, R.A. and Carey, F. Paper in preparation.

    Google Scholar 

  6. Masters, D.J. and McMillan, R.M. (1983). Improved reversed phase HPLC assay for LTB4. In Leukotrienes and other Lipoxygenase Products (ed. P.J. Piper) Wiley, Chichester, pp. 275–276.

    Google Scholar 

  7. Dahlen, S-E., Bjork, J., Hedqvist, P., Arfors, K-E., Hammarstrom, S., Lindgren, J-A. and Samuelsson, B. (1981). Leukotrienes promote plasma leakage and leukocyte adhesion in posteapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA, 78, 3887–3891.

    Article  Google Scholar 

  8. Peck, M.J., Piper, P.J. and Williams, T.J. (1981). The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins, 21, 315–321.

    Article  Google Scholar 

  9. Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E. and Smith, M.J.H. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature, 286, 264–265.

    Article  Google Scholar 

  10. Goetzl, E.J. and Pickett, W.C. (1980). The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J. Immunol., 125, 1789–1791.

    Google Scholar 

  11. Wedmore, C.V. and Williams, T.J. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature, 289, 646–650.

    Article  Google Scholar 

  12. Simmons, P.M., Salmon, J.A. and Moncada, S. (1983). The release of leukotriene B4 during experimental inflammation. Biochem. Pharmac, 32, 1353–1359.

    Google Scholar 

  13. Levine, J.D., Lau, W., Kwiat, G. and Goetzl, E.J. (1984). Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science, 225, 743–745.

    Article  Google Scholar 

  14. Palmer, R.M.J. and Yeats, D.A. (1981). Leukotriene B: A potent chemotactic agent and stimulus for lysosomal enzyme secretion for human neutrophils (PMN). Brit. J. Pharmacol., 73, 260–261P.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 1985 The Contributors

About this chapter

Cite this chapter

Haworth, D., Carey, F. (1985). Identification of Immunoreactive LTB4 in the Yeast-inflamed Rat Paw. In: Higgs, G.A., Williams, T.J. (eds) Inflammatory Mediators. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07834-9_4

Download citation

Publish with us

Policies and ethics